SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    F.-K. F. Cheng, D. M. Torres, S. A. Harrison, Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy?, Journal of Viral Hepatitis, 2014, 21, 1
  2. 2
    Alessandra Mangia, Maria Ripoli, Insulin resistance, steatosis and hepatitis C virus, Hepatology International, 2013, 7, S2, 782

    CrossRef

  3. 3
    Stéphanie Pascarella, Sophie Clément, Michael T. Dill, Stéphanie Conzelmann, Martin Lagging, Gabriele Missale, Avidan U. Neumann, Jean-Michel Pawlotsky, Stefan Zeuzem, Laura Rubbia-Brandt, Pierre-Yves Bochud, Francesco Negro, Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C, Liver International, 2013, 33, 1
  4. 4
    Dariusz Suchy, Krzysztof Łabuzek, Grzegorz Machnik, Michał Kozłowski, Bogusław Okopień, SOCS and diabetes—ups and downs of a turbulent relationship, Cell Biochemistry and Function, 2013, 31, 3
  5. 5
    Munechika Enjoji, Motoyuki Kohjima, Kazuhiro Kotoh, Makoto Nakamuta, Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  6. 6
    Elisabetta Bugianesi, Federico Salamone, Francesco Negro, The interaction of metabolic factors with HCV infection: Does it matter?, Journal of Hepatology, 2012, 56, S56

    CrossRef